CLINICAL_TRIALS
trial_result
· 2017-03-03
Clinical Trial Update: Salt Intake and Antiproteinuric Effect of Paricalcitol in Type 2 Diabetes [Phase 2]
Summary
A completed Phase 2 trial evaluated whether salt intake affects the antiproteinuric effect of paricalcitol in people with type 2 diabetes.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED